| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 08/05/2010 | CA2750409A1 Conformationally dynamic peptides |
| 08/05/2010 | CA2750269A1 Crystalline insulin-conjugates |
| 08/05/2010 | CA2750007A1 Plants having enhanced yield-related traits and a method for making the same |
| 08/05/2010 | CA2749708A1 Engineering nf-yb transcription factors for enhanced drought resistance and increased yield in transgenic plants |
| 08/05/2010 | CA2749325A1 Simian adenovirus nucleic acid- and amino acid-sequences, vectors containing same, and uses thereof |
| 08/05/2010 | CA2748937A1 Urine and serum biomarkers associated with diabetic nephropathy |
| 08/05/2010 | CA2748852A1 Biomarkers associated with nephropathy |
| 08/05/2010 | CA2748500A1 Measuring g protein coupled receptor activation |
| 08/04/2010 | EP2213752A1 Recombinant Newcastle disease virus RNA expression systems and vaccines |
| 08/04/2010 | EP2213745A1 Improved bacillus host cell |
| 08/04/2010 | EP2213743A1 Albumin fusion proteins |
| 08/04/2010 | EP2213742A1 Chimeric antigens for breaking host tolerance to foreign antigens |
| 08/04/2010 | EP2213740A1 Human telomerase catalytic subunit |
| 08/04/2010 | EP2213735A1 Peptide imparting antibody-binding ability to liposome and liposome modified with the same |
| 08/04/2010 | EP2213732A1 Hybrid glucoamylases |
| 08/04/2010 | EP2213684A2 Nogo-a antibodies for the treatment of Alzheimer disease |
| 08/04/2010 | EP2213682A1 TSLP promotes immune evasion and persistence of viruses |
| 08/04/2010 | EP2213681A1 Novel Bacillus thuringiensis insecticidal proteins |
| 08/04/2010 | EP2213300A1 Composition and method for treating cancer using herpes virus |
| 08/04/2010 | EP2213298A2 Immunogenic compositions of staphylococcus epidermidis polypeptide and polynucleotide antigens |
| 08/04/2010 | EP2213297A1 Staphylococcus aureus antigenic polypeptides |
| 08/04/2010 | EP2213295A1 A method for obtaining data useful in the identification of a patient at risk of having difficulty in sustaining a pregnancy |
| 08/04/2010 | EP2213287A1 Inhibition of biofilm formation |
| 08/04/2010 | EP2212431A2 Antibodies to irem-1 |
| 08/04/2010 | EP2212352A1 New synthetic arginine substituted peptides and their use |
| 08/04/2010 | EP2212351A1 Oxidant resistant apolipoprotein a-1 and mimetic peptides |
| 08/04/2010 | EP2212350A1 Therapeutic and diagnostic methods using tim-3 |
| 08/04/2010 | EP2212349A1 Synthetic analogues of neural regeneration peptides |
| 08/04/2010 | EP2212348A1 Materials and methods for gene mediated therapy of psychiatric disorders |
| 08/04/2010 | EP2212347A1 Soluble gp130 muteins with improved binding activity |
| 08/04/2010 | EP2212346A2 Plants with altered root architecture, related constructs and methods involving genes encoding exostosin family polypeptides and homologs thereof |
| 08/04/2010 | EP2212345A1 Poxviral oncolytic vectors |
| 08/04/2010 | EP2212344A2 Use of slit, nephrin, ephrin or semaphorin for treatment of cartilage diseases |
| 08/04/2010 | EP2212343A2 Peptide gap junction modulators |
| 08/04/2010 | EP2211891A2 Antagonists of kisspeptin and uses thereof |
| 08/04/2010 | EP1711834B1 Process for screening glycoform-specific antibodies |
| 08/04/2010 | EP1708746B1 Recombinant vaccine against japanese encephalitis virus [jev] infection and a method thereof |
| 08/04/2010 | EP1636365B1 Cholesterol biosynthesis pathway modulators and uses thereof |
| 08/04/2010 | EP1599497B1 Crystal structure of the ternary complex of 14-3-3, fusicoccin, and plasma membrane atpase and methods for designing new herbicides |
| 08/04/2010 | EP1572931B1 Methods and compositions for modulating and detecting wisp activity |
| 08/04/2010 | EP1460134B1 SUGAR TRANSFERASE GnT-V HAVING ANGIOGENIC EFFECT |
| 08/04/2010 | EP1430134B1 Hdv nucleic acid molecules, fragments and applications thereof |
| 08/04/2010 | EP1185660B1 Porcine circovirus vaccine in recombinant poxvirus |
| 08/04/2010 | EP1032675B1 Attaching substances to micro-organisms |
| 08/04/2010 | EP0748386B9 Production of fibrinogen in transgenic animals |
| 08/04/2010 | CN201538749U Instant reactor for bio-pharmaceuticals |
| 08/04/2010 | CN1756840B Method of inducing homologous recombination of somatic cell |
| 08/04/2010 | CN1728939B Generation of plants with altered oil content |
| 08/04/2010 | CN101796415A Novel liver cancer marker |
| 08/04/2010 | CN101796190A Novel viral vector for the expression of heterologous sequences |
| 08/04/2010 | CN101796071A Rapid acting insulin analogues |
| 08/04/2010 | CN101796070A P53 peptide vaccine |
| 08/04/2010 | CN101796069A Vm23 and Vm24, two scorpion peptides that block human T-lymphocyte potassium channels (sub-type Kv1.3) with high selectivity and decrease the in vivo DTH-responses in rats |
| 08/04/2010 | CN101796068A RHD6 and its use in modulating plant root hair development |
| 08/04/2010 | CN101796067A Lantibiotic-based compounds having antimicrobial activity |
| 08/04/2010 | CN101796065A Method for purifying the factor VIII and the Von Willebrand factor |
| 08/04/2010 | CN101796064A Method for producing peptide |
| 08/04/2010 | CN101795705A intradermal hpv peptide vaccination |
| 08/04/2010 | CN101792770A Photoperiodic tolerant mutant hd1-3 gene for regulating and controlling flowering time of rice and application thereof |
| 08/04/2010 | CN101792767A Fully artificial synthesis and water soluble expression of porcine alpha-interferon gene |
| 08/04/2010 | CN101792759A Immune co-enhancing molecule prepared by genetic engineering and immunopotentiation application thereof |
| 08/04/2010 | CN101792738A Cell strain of monoclonal antibody against ciprofloxacin and monoclonal antibody thereof |
| 08/04/2010 | CN101792490A Method for recycling albumin in Cohn's fraction IV precipitate |
| 08/04/2010 | CN101792489A Preparation and application of human galectin-9 deletant for enhancement of immune response |
| 08/04/2010 | CN101792488A Cotton disease resistance related transcription factor MEREB2, and protein encoding gene and application thereof |
| 08/04/2010 | CN101792482A Method for purifying gonadotropins |
| 08/04/2010 | CN101792481A Purification method of human chorionic gonadotropin (HCG) |
| 08/04/2010 | CN101791409A peptide vectors |
| 08/04/2010 | CN101503463B Novel Bt protein Cry53Ab1, coding gene thereof and use |
| 08/04/2010 | CN101497657B Novel disinsection Bt protein Cry54Aa1, coding gene thereof and use |
| 08/04/2010 | CN101265294B Disease-resistant correlated wheat MYB albumen and coding gene |
| 08/03/2010 | US7767886 Comprises restoration of fertility (RF) polypeptide comprising pentatricopeptide repeat (PPR) for restoring fertility to male sterile plants; genetic engineering and selective plant breeding |
| 08/03/2010 | US7767884 Method of repressing flowering in a plant |
| 08/03/2010 | US7767881 Mixture of histamine receptor protein and histamine receptor antagonist |
| 08/03/2010 | US7767872 Comprises a dosing device or a solid support having at least one substantially purified metallothionein protein; removing heavy metals from drugs and biologically active material |
| 08/03/2010 | US7767800 Comprises lymphadenopathy viral sequences for diagnosis of aquired immuno-depressive syndromes |
| 08/03/2010 | US7767795 High pressure refolding of protein aggregates and inclusion bodies |
| 08/03/2010 | US7767793 Monolconal antibody specific to single immunoglobulin and toll-interleukin-1 receptor domain (SIGIRR) for treatment of rheumatoid arthritis, osteoporosis and inflammatory bowel diseases |
| 08/03/2010 | US7767792 Monoclonal antibody specific to epidermal growth factor receptor for targeting tumors and treating cancer; tissue targeted therapy |
| 08/03/2010 | US7767790 Apotosis inducing viral protein, in combination with defective p53 protein, for use in treatment of cell proliferative and autoimmune disorders |
| 08/03/2010 | US7767789 Truncated proteins as cancer markers |
| 08/03/2010 | US7767788 Folding protein functioning as a molecular switch |
| 08/03/2010 | US7767787 Substance for obtaining highly effective tumor medications as well as a process |
| 08/03/2010 | US7767786 Neural regeneration peptides and methods for their use in treatment of neural injury or degeneration |
| 08/03/2010 | US7767644 contains at least four amino acids selected from leucine, isoleucine, threonine, glutamic acid, aspartic acid and phenylalanine, and in which the addition of preservatives, urea or human serum albumine can be foregone; storage stability |
| 08/03/2010 | US7767643 A reduced carbohydrate or oxidized carbohydrates links to erythropoietin; cognitive activator for treating nervous system disorder, anticardiovascular agents, treating vision defects, respiratory diseases, kidney and urinary diseases |
| 08/03/2010 | US7767641 promoting endothelial cell adhesion, spreading and migration in treating a condition or disease characterized by pathological vascular remodeling in a subject in need thereof by administering a composition comprising Nogo-B or a fragment of Nogo-B comprising 1- 200 of the N-terminus |
| 08/03/2010 | US7767450 Nucleotide sequences coding voltage-gated transport proteins for use as screening tools to identify modulators for treatment and prevention of nervous, muscular, glandular, immune, reproductive and epithelial tissue disorders |
| 08/03/2010 | US7767449 Methods using modified vaccinia virus |
| 08/03/2010 | US7767429 use to treat glycosaminoglycan associated pathologies such as eye disorders or tumors; sialated and pegylated forms of a recombinant sHASEGP to enhance stability and serum pharmacokinetics over naturally occurring slaughterhouse enzymes; transgenic animals; dosage forms; HYLENEX RECOMBINANT tradename |
| 08/03/2010 | US7767424 Cloning and characterization of the broad-spectrum resistance gene PI2 |
| 08/03/2010 | US7767418 Expression vector comprising nucleotide sequences coding immunoglobulin fusion comprising transient receptor potential cation channel for use in identifying modulator for treatment and prevention of nervous system disorders |
| 08/03/2010 | US7767417 Prenyl-electrostatic switch, and methods of use |
| 08/03/2010 | US7767398 Nucleotide sequences comprising mutation in untranslated coding region of ATP-gated ion channel (P2X7R) for use as tool in diagnosing psychological disorders |
| 08/03/2010 | US7767392 Nucleotide sequences coding zinc finger protein for use in identifying modulators of cell proliferation disorders; antitumor agents |
| 08/03/2010 | US7767387 Therapeutic targets in cancer |
| 08/03/2010 | US7767211 S.aureus polypeptides |
| 08/03/2010 | US7767201 Vascular cells genetically altered to over-express angiogenic proliferation and maturation factors; treatment of atherosclerosis using same |
| 08/03/2010 | US7767199 Expression vector comprising interleukin-21sequences for use in improved transcription of exogenous nucleotide sequences |
| 08/03/2010 | US7767198 Aerosolizing dry powder of interleukin-4 receptor with carbohydrage, lipid, buffer, peptide, protein, Group II metal, or oligopeptide excipient; small aerodynamic particle size; dispersion into gas stream to make inhalant; high dispersibilities |